Gliomas
Gliomas are the primary brain tumors of the central nervous system. The prognosis, especially for high-grade gliomas, is dismal; the treatment of these tumors represents an unmet need in medicine. This book, contributed by an excellent team of clinicians and basic scientists, touches upon several cr...
में बचाया:
| स्वरूप: | Online |
|---|---|
| भाषा: | अंग्रेज़ी |
| प्रकाशित: |
Exon Publications
2022
|
| विषय: | |
| ऑनलाइन पहुंच: | https://directory.doabooks.org/handle/20.500.12854/81837 |
| टैग: |
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|
| _version_ | 1869529315256827904 |
|---|---|
| collection | Directory of Open Access Books |
| description | Gliomas are the primary brain tumors of the central nervous system. The prognosis, especially for high-grade gliomas, is dismal; the treatment of these tumors represents an unmet need in medicine. This book, contributed by an excellent team of clinicians and basic scientists, touches upon several critical aspects of glioma research and clinical therapies. There is a considerable emphasis on translational efforts. The 13 chapters of the book cover aspects of clinically-relevant models, glioma stem-like cells, IDH mutations, integrated approach for better patient outcome, abnormal cholesterol and other metabolic processes, bioinformatics for survival prediction, molecular signature for prognostication, neuro-functional monitoring during surgery, glioma-related epilepsy, and glioneuronal tumors along with various natural and synthetic drug candidates currently under evaluation. As such, the individual contributions provide a glimpse on the magnitude of challenges and potential solutions in a variety of research areas. This book will likely be interest to a wide audience seeking more information on challenges gliomas present to both scientists and clinicians. |
| format | Online |
| id | doab-20.500.12854ir-81837 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2022 |
| publishDateRange | 2022 |
| publishDateSort | 2022 |
| publisher | Exon Publications |
| publisherStr | Exon Publications |
| record_format | ojs |
| spelling | doab-20.500.12854ir-818372022-05-22T00:42:41Z Gliomas Debinski, Waldemar Gliomas; Pre-Clinical Models for Glioblastoma; Novel Therapies for Glioblastomas; Mouse Models of Glioblastoma; Cancer Stem Cells in Pediatric Brain Tumors; IDH1 in Glioma; Improve Outcomes for Glioma Patients; Cholesterol Derivatives for Glioblastoma; Metabolic Therapy for Glioblastoma; Targeting Energy Metabolism for Glioblastoma; Resistance of Glioblastoma; Tumor-associated Edema; Curcumin for Gliomas; Survival Prediction in Gliomas; Molecular Markers of Gliomas; Prediction of Treatment and Prognosis of Gliomas; Brain Mapping for Gliomas; Neuropsychological Testing during Low-Grade Tumor Resection; Pathogenesis of Brain Tumor-Related Epilepsy; Management of Brain Tumor-Related Epilepsy; Glioneuronal Tumors MJCL Gliomas are the primary brain tumors of the central nervous system. The prognosis, especially for high-grade gliomas, is dismal; the treatment of these tumors represents an unmet need in medicine. This book, contributed by an excellent team of clinicians and basic scientists, touches upon several critical aspects of glioma research and clinical therapies. There is a considerable emphasis on translational efforts. The 13 chapters of the book cover aspects of clinically-relevant models, glioma stem-like cells, IDH mutations, integrated approach for better patient outcome, abnormal cholesterol and other metabolic processes, bioinformatics for survival prediction, molecular signature for prognostication, neuro-functional monitoring during surgery, glioma-related epilepsy, and glioneuronal tumors along with various natural and synthetic drug candidates currently under evaluation. As such, the individual contributions provide a glimpse on the magnitude of challenges and potential solutions in a variety of research areas. This book will likely be interest to a wide audience seeking more information on challenges gliomas present to both scientists and clinicians. Published 2022-05-22T00:42:39Z 2022-05-22T00:42:39Z 2021-04-30 book 9780645001747 https://directory.doabooks.org/handle/20.500.12854/81837 eng image/png Attribution-NonCommercial-NoDerivatives 4.0 International https://exonpublications.com/index.php/exon/issue/view/15 Exon Publications 10.36255/exonpublications.gliomas.2021 10.36255/exonpublications.gliomas.2021 2d6001a3-9e06-4979-bf02-6974e313eb24 9780645001747 233 Australia open access |
| spellingShingle | Gliomas; Pre-Clinical Models for Glioblastoma; Novel Therapies for Glioblastomas; Mouse Models of Glioblastoma; Cancer Stem Cells in Pediatric Brain Tumors; IDH1 in Glioma; Improve Outcomes for Glioma Patients; Cholesterol Derivatives for Glioblastoma; Metabolic Therapy for Glioblastoma; Targeting Energy Metabolism for Glioblastoma; Resistance of Glioblastoma; Tumor-associated Edema; Curcumin for Gliomas; Survival Prediction in Gliomas; Molecular Markers of Gliomas; Prediction of Treatment and Prognosis of Gliomas; Brain Mapping for Gliomas; Neuropsychological Testing during Low-Grade Tumor Resection; Pathogenesis of Brain Tumor-Related Epilepsy; Management of Brain Tumor-Related Epilepsy; Glioneuronal Tumors MJCL Gliomas |
| title | Gliomas |
| title_full | Gliomas |
| title_fullStr | Gliomas |
| title_full_unstemmed | Gliomas |
| title_short | Gliomas |
| title_sort | gliomas |
| topic | Gliomas; Pre-Clinical Models for Glioblastoma; Novel Therapies for Glioblastomas; Mouse Models of Glioblastoma; Cancer Stem Cells in Pediatric Brain Tumors; IDH1 in Glioma; Improve Outcomes for Glioma Patients; Cholesterol Derivatives for Glioblastoma; Metabolic Therapy for Glioblastoma; Targeting Energy Metabolism for Glioblastoma; Resistance of Glioblastoma; Tumor-associated Edema; Curcumin for Gliomas; Survival Prediction in Gliomas; Molecular Markers of Gliomas; Prediction of Treatment and Prognosis of Gliomas; Brain Mapping for Gliomas; Neuropsychological Testing during Low-Grade Tumor Resection; Pathogenesis of Brain Tumor-Related Epilepsy; Management of Brain Tumor-Related Epilepsy; Glioneuronal Tumors MJCL |
| topic_facet | Gliomas; Pre-Clinical Models for Glioblastoma; Novel Therapies for Glioblastomas; Mouse Models of Glioblastoma; Cancer Stem Cells in Pediatric Brain Tumors; IDH1 in Glioma; Improve Outcomes for Glioma Patients; Cholesterol Derivatives for Glioblastoma; Metabolic Therapy for Glioblastoma; Targeting Energy Metabolism for Glioblastoma; Resistance of Glioblastoma; Tumor-associated Edema; Curcumin for Gliomas; Survival Prediction in Gliomas; Molecular Markers of Gliomas; Prediction of Treatment and Prognosis of Gliomas; Brain Mapping for Gliomas; Neuropsychological Testing during Low-Grade Tumor Resection; Pathogenesis of Brain Tumor-Related Epilepsy; Management of Brain Tumor-Related Epilepsy; Glioneuronal Tumors MJCL |
| url | https://directory.doabooks.org/handle/20.500.12854/81837 |